PLRX PLIANT THERAPEUTICS INC

Ownership history in CITIGROUP INC  ·  25 quarters on record

This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in PLIANT THERAPEUTICS INC (PLRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 4,319 -19,605 -81.9% 0.00% $6K $1.48
2025 Q2 REDUCED 23,924 -21,619 -47.5% 0.00% $28K $1.16
2025 Q1 REDUCED 45,543 -7,038 -13.4% 0.00% $61K $1.35
2024 Q4 ADDED 52,581 +3,041 +6.1% 0.00% $692K $13.17
21 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PLRX price (monthly, adj. close)
← Back to CITIGROUP INC Holdings